McDonald’s is changing its menu for the Ozempic era

McDonald’s is adapting to the “Ozempic era,” investing $8.5 billion in a decade-long transformation of its restaurants to cater to changing eating habits. According to Gallup data, about 11% of the US population uses GLP-1 medications for weight loss, prompting a surge in demand for protein-rich products. At the company’s investor day on September 23, McDonald’s executives unveiled plans to introduce protein-packed menu items such as wraps, grilled chicken sandwiches, bowls, and egg bites across various markets.

Skye Anderson, president of McDonald’s USA, sees this as an opportunity to retain customers, emphasizing the need to offer compelling reasons for them to choose McDonald’s. To modernize the restaurants, McDonald’s will implement lockers for delivery orders, improved kitchen layouts, and AI-enabled technology to enhance productivity.

The AI system, developed with Google and known as ArchIQ, will track inventory, schedule, and take orders in Spanish and English via the drive-thru. Additionally, the in-dining experience will be improved with larger play areas and more visible coffee preparation. However, these upgrades come at a significant cost, with individual franchise owners expected to spend nearly double their current remodel expenses over a decade.

Despite investor concerns, with McDonald’s shares declining by nearly 5% following the announcement, McDonald’s Chairman and CEO Chris Kempczinski remains committed to thoughtful AI integration in the company’s strategy.